Vista, California and Christchurch, New Zealand (Summer, 2006) – Phoenix Biologics Inc. announces an agreement with Migco Pharmaceuticals Ltd. to manufacture and distribute a new natural health product targeted at migraine prevention. The new dietary supplement will strengthen the PBI product line and its mission to provide natural choices for health and well-being. Migco Pharmaceuticals Ltd. will be supporting the product with scientific data and studies.
Earlier this year, Migco Pharmaceuticals Ltd. was granted a patent based on the findings from the study by Dr. Chayasirisobhon of Kaiser Permanente published in May 2006 issue of the journal Headache. The study links the use of Monterey pine (Pinus radiata extract) to a reduction in incidence and intensity of migraine headaches. Phoenix Biologics Inc. has the licensing agreement to manufacture the product Liberate®. Liberate® will contain the branded ingredient Preoxus® (Monterey pine - Pinus radiata extract) from Migco Pharmaceuticals Ltd.
Liberate® is available now through Phoenix Biologics Inc. The first exposure of the product to the public created a high level of interest at the California Governors and First Ladies Conference on Women this September in Long Beach California. The product website has recently gone live at www.liberatemigraines.com. The future plans for the website will be an expansion to include a comprehensive resource for migraine sufferers.
In making the announcement, Jenny Stepien, Sales Director of Phoenix Biologics Inc. said “PBI shares with Migco similar values and goals. We both believe in a foundation built upon quality products with strong science. The products are developed to provide proven natural choices for integrative care and to bring relief to those suffering from specific ailments.”
About Phoenix Biologics Inc.
Phoenix Biologics Inc manufactures it’s own line of products featuring VitaCarte® dietary supplement. In addition Phoenix Biologics Inc handles distribution and fulfillment of the Levity® products from Geneva Health & Nutrition LLC among other products. Partnerships with these companies enhance the diversity of PBI and the services offered to manufacturers, distributors, retailers and direct customers.
About Migco Pharmaceuticals Ltd.
Migco Pharmaceuticals Ltd. is focused on developing and bringing to market innovative therapeutic products that will significantly improve the lives of those suffering from migraines. Complementing its gene based development platform, Migco has formed strategic alliances with leading migraine researchers, geneticists, and practicing neurologists to rapidly pursue the goal of reducing the incidence of migraine headaches.